Determinants of real-world functional performance in schizophrenia subjects: Correlations with cognition, functional capacity, and symptoms
DOI 10.1176/appi.ajp.163.3.418
Bowie CR, Reinchenberg A, Patterson TL, et al. Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. Am J Psychiatry. 2006;163:418-425. (Pubitemid 44469383)
Prediction of real-world functional disability in chronic mental disorders: A comparison of schizophrenia and bipolar disorder
Bowie CR, Depp C, McGrath JA, et al. Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder. Am J Psychiatry. 2010;167:1116-1124.
Cilostazol: A new drug in the treatment intermittent claudication
DOI 10.2174/157489007782418991
Kumar M, Bhattacharya V. Cilostazol: a new drug in the treatment intermittent claudication. Recent Pat Cardiovasc Drug Discov. 2007;2:181-185. (Pubitemid 350200286)
Effects of cilostazol on dizocilpine-induced hyperlocomotion and prepulse inhibition deficits in mice
Hashimoto K, Fujita Y, Horio M, et al. Effects of cilostazol on dizocilpine-induced hyperlocomotion and prepulse inhibition deficits in mice. Clin Psychopharmacol Neurosci. 2010;8:74-78.
Effects of cilostazol on cognitive deficits in mice after repeated administration of phencyclidine
Hashimoto K, Fujita Y, Ishima T, et al. Effects of cilostazol on cognitive deficits in mice after repeated administration of phencyclidine. Clin Psychopharmacol Neurosci. 2010;8:26-29.